Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials -...

  • Monday, May 14, 2012, 11:45 AM ET
    Biotech ETFs are near all-time highs despite overall market weakness, due to successful trials - e.g. for Vertex's (VRTX) cystic fibrosis treatment - and because some investors are betting on deals occurring. One ETF that is doing particularly well this year is iShares Nasdaq Biotech (IBB). Others include XBI, FBT and BBH.
Track new comments on this story

This news story has 6 comments:

  •  
    I guess there may be some people out there who aren't already aware of this, but if there are, I hope(for their sake) they aren't biotech investors-

    It's always important to be aware of the sector trend of your investments.

    I think the other important point, concerning the current outperformance of the biotech sector, relates to anticipated positive surprises at ASCO 2012.

    The related risk, of course, is that, in view of the overall mkt weakness, you'll see a catch-up selloff on the news-

    what is and isn't priced in???
    14 May 2012, 03:00 PM Reply Like
  •  
    IBB have a not bad looking chart over a long period ?
    16 May 2012, 02:22 PM Reply Like
  •  
    And biotech continues to hit new highs this month. XBI is up nearly 3% today
    27 Jun 2012, 01:56 PM Reply Like
  •  
    Today the XBI is down about 4%. Any recommendation for this ETF?
    19 Oct 2012, 04:22 PM Reply Like
  •  
    Probably a good long term entry point. Hasn't been below 90 in awhile
    20 Oct 2012, 07:42 AM Reply Like
  •  
    Hope you got in.... $110ish as we speak
    21 May, 12:32 AM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »